Abstract
The goal of adjuvant chemotherapy in the treatment of carcinomas is improved survival for patients treated with local therapy. It has been shown that adjuvant chemotherapy improves survival in a variety of animal models and in humans with breast cancer, osteosarcoma, or colorectal cancer. The central hypothesis is that chemotherapy eradicates micrometastatic or residual local disease early on.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Leone LA, Albala MM, Rege VB. Treatment of carcinoma of the head and neck with intravenous methotrexate. Cancer 21:828–837, 1968.
Morton RP, Stell PM. Cytotoxic chemotherapy for patients with terminal squamous carcinoma —does it influence survival? Clin Otolaryngol 9:175–180, 1984.
Pinto HA, Jacobs C. Chemotherapy for recurrent and metastatic head and neck cancer. Hematol Oncol Clin North Am 5:667–686, 1991.
Lo TCM, Wiley AL, Ansfleld FJ, Brandenburg JH, Davis HL, Gollin FF, et al. Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study. Radiat Ther Nuclear Med 126:229–235, 1975.
Shanta V, Krishnamurthi S. Combined bleomycin and radiotherapy in oral cancer. Clin Radiol 31:617–620, 1980.
Weissberg JB, Yung HS, Papac RJ, Sasaki C, Fischer S, Lawrence R, Rockwell S, et al. Randomized trial of mitomycin-C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 17:3–9, 1989.
Marcial VA, Pajak TF, Mohiuddin M, Cooper JS, Sarraf MA, Mowry PA, et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Cancer 66:1861–1868, 1990.
Merlano M, Vitale V, Rosso R, Benasso M, Corvo R, Cavallari M, et al. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327:1115–1121, 1992.
Jacobs CJ, Goffinet DR, Goffinet L, Kohler M, Fee WE. Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer 60:1178–1183, 1987.
The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690, 1991.
Vokes EE, Mick R, Lester EP, Panje WR, Weichselbaum, RR. Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: Results from a single institution. J Clin Oncol 9:1376–1384, 1991.
Tannock I, Browman G. Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. J Clin Oncol 4:1121–1126, 1984.
Jacobs CJ. Adjuvant chemotherapy for head and neck cancer. J Clin Oncol 7:823–826, 1989.
Fu KK, Phillips TL, Silverberg IJ, Jacobs C, Goffinet D, Chun C, et al. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 5:1410–1418, 1987.
Head and Neck Contracts Program. Adjuvant chemotherapy for advanced head and neck squamous carcinoma: Final report of the Head and Neck Contracts Program. Cancer 60:301–311, 1987.
Schuller DE, Stein DW, Metch B. Analysis of treatment failure patterns. A Southwest Oncology Group study. Arch Otoloaryngol Head Neck Surg 115:834–836, 1989.
Laramore GE, Scott CB, Al-Sarraf M, Haselow RE, Ervin TJ, Wheeler R, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup study 0034. Int J Radiat Oncol Biol Phys 23:705–713, 1992.
Crile CW. Excision of cancer of the head and neck. JAMA 47:1780–1785, 1906.
Crile CW. Cancer of jaws, tongue, cheeks and lips. Surg Gynecol Obstet 36:159–162, 1923.
Dorrance GM, McShane JK. Cancer of the tongue and floor of the mouth. Ann Surg 88:1007–1021, 1928.
Castigliano SG, Rominger CJ. Distant metastasis from carcinoma of the oral cavity. Am J Roentgenol 71:997–1006, 1954.
Price LW. Metastasis in squamous carcinoma. Am J Cancer 22:1–16, 1934.
Willis RA. The Spread of Tumors in the Human Body. London: JA Churchill, 1934.
Braund RR, Martin HE. Distant metastasis in cancer of the upper respiratory and alimentary tracts. Surg Gynecol Obstet 73:63–71, 1941.
Peltier LF, Thomas LB, Barclay THC, Kremen AJ. The incidence of distant metastases among patients dying with head and neck cancers. Surgery 30:827–833, 1951.
Hoye RC, Herrold KM, Smith RR, Thomas LB. A clinicopathological study of epidermoid carcinoma of the head and neck. Cancer 15:741–749, 1962.
Ju DMC. A study of the behavior of cancer of the head and neck during its late and terminal phases. Am J Surg 108:552–557, 1964.
O’Brien PH, Carlson R, Steubner EA, Staley CT. Distant metastases in epidermoid cell carcinoma of the head and neck. Cancer 27:304–307, 1971.
Dennington ML, Carter DR, Meyers AD. Distant metastases in head and neck epidermoid carcinoma. Laryngoscope 90:196–201, 1980.
Kotwall C, Sako K, Razack S, Rao U, Bakamjian V, Shedd DP. Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg 154:439–442, 1987.
Zbären P, Lehmann W. Frequency and sites of distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 113:762–764, 1987.
Arons MS, Smith RR. Distant metastases and local recurrence in head and neck cancer. Ann Surg 154:235–240, 1961.
Rubenfeld S, Kaplan G, Holder AA. Distant metastases from head and neck cancer. Am J Roentgenol 87:441–448, 1962.
Probert JC, Thompson RW, Bagshaw MA. Patterns of spread of distant metastases in head and neck cancer. Cancer 33:127–133, 1974.
Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 40:145–151, 1977.
Vikram B, Strong EW, Shah JP, Spiro R. Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg 6:730–733, 1984.
Amdur RJ, Parsons JT, Mendenhall WM, Million RR, Stringer SP, Cassisi NJ. Postoperative irradiation for squamous cell carcinoma of the head and neck: An analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 16:25–36, 1989.
Loree TR, Strong EW. The significance of positive margins in oral cavity squamous carcinoma. Am J Surg 160:410–414, 1990.
Cerezo L, Millan I, Torre A, Aragon G, Otero J. Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. Cancer 69:1224–1234, 1991.
Roland NJ, Caslin AW, Nash J, Stell PM. Value of grading squamous cell carcinoma of the head and neck. Head Neck 14:224–229, 1992.
Berger DS, Fletcher GH. Distant metastases following local control of squamous cell carcinoma of the nasopharynx, tonsillar fossa, and base of the tongue. Radiology 10:141–143, 1971.
Gowen GF, DeSuto-Nagy G. The incidence and sites of distant metastases in head and neck carcinoma. Surg Gynecol Obstet 116:603–607, 1963.
Bisel HF, Wróblewski F, LaDue JS. Incidence and clinical manifestations of cardiac metastases. JAMA 153:712–715, 1953.
Hanfling SM. Metastatic cancer to the heart. Circulation 22:474–483, 1960.
Burke EM. Metastases in squamous cell carcinoma. Am J Cancer 30:493–503, 1937.
Brennan CT, Sessions DG, Spitznagel EL, Harvey JE. Surgical pathology of cancer of the oral cavity and oropharynx. Laryngoscope 101:1175–1197, 1991.
Marks JE, Kurnik B, Powers WE, et al. Carcinoma of the pyriform sinus: An analysis of treatment results and patterns of failure. Cancer 41:1008–1015, 1978.
Kalnins IK, Leonard Ag, Sako K, Pazak MS, Shedd DP. Correlation between prognosis and degree of lymph node involvement in carcinoma of the oral cavity. Am J Surg 134:450–454, 1977.
Snow GB, Annyas AA, Van Slooten EA, Bartelink H, Hart AAM. Prognostic factors of neck node metastasis. Clin Otolaryngol 7:185–192, 1982.
Hirabayashi H, Koshii K, Uno K, Ohgaki H, Nakasone Y, Fujisawa T, et al. Extracapsular spread of squamous cell carcinoma in neck nodes: Prognostic factor of laryngeal cancer. Laryngoscope 101:502–506, 1991.
Johnson JT, Meyers EN, Mayernik DG, Nolan TA, Sigler BA, Wagner RL. Adjuvant methotrexate-5-fluorouracil for extracapsular squamous cell carcinoma in cervical metastasis. Laryngoscope 100:590–592, 1990.
McGuirt WF, McCabe BF. Significance of node biopsy before definitive treatment of cervical metastatic carcinoma. Laryngoscope 88:594–597, 1978.
McGuirt WF. Diagnosis and management of masses in the neck, with special emphasis on metastatic malignant disease. Oncology 4:85–98, 1990.
Smith EH. The hazards of fine-needle aspiration biopsy. Ultrasound Med Biol 10:629–634, 1984.
Foussel F. Risk of metastasis during fine-needle aspiration. J Clin Pathol 43:878–879, 1990.
Jakobsson PA, Enroth CM, Killander D, Moberger G, Mårtenson B. Histologic classification and grading in carcinoma of the larynx. Acta Radiol Ther Phys Biol 12:1–8, 1973.
Crissman JD, Liu WY, Gluckman JL, Cummings G. Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer 54:2995–3001, 1984.
Bundgaard T, Sørensen FB, Gaihede M, Søgaard H, Overgaard J. Stereologic, histo-lopathologic, flow cytometric, and clinical parameters in the prognostic evaluation of 74 patients with intraoral squamous cell carcinomas. Cancer 70:1–13, 1992.
Zatterstrom UK, Wennerberg J, Ewers SB, Willen R, Attewell R. Prognostic factors in head and neck cancer: Histologic grading, DNA ploidy, and nodal status. Head Neck 13:477–487, 1991.
Truelson JM, Fisher SG, Beals TE, McClatchey KD, Wolf GT. DNA content and histologic growth pattern correlate with prognosis in patients with advanced squamous cell carcinoma of the larynx. Cancer 70:56–62, 1992.
Dabelsteen E, Clausen H, Mandel U. Aberrant glycosylation in oral malignant and pre-malignant lesions. J Oral Pathol Med 20:361–368, 1991.
Schantz SP. Experimental head and neck onocology. Curr Opin Oncol 4:478–484, 1992.
Byrne M, Eide GE, Lilleng R, Langmark F, Thrane PS, Dabelsteen E. A multivariate study of the prognosis of oral squamous cell carcinomas: Are blood group and hemoglobin new prognostic factors? Cancer 68:1994–1998, 1991.
Wolf GT, Carey TE, Schmaltz SP, McClatchey KD, Poore J, Glaser L, et al. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck. J Natl Cancer Inst 82:1566–1572, 1990.
Jacobs CJ, Makuch R. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of the Head and Neck Contracts Program. J Clin Oncol 8:838–847, 1990.
Schuller DE, Metch B, Stein DW, Mattox D, McCracken JD. Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group. Laryngoscope 98:1205–1211, 1988.
Taylor SG, Applebaum E, Showel JL, Norusis M, Holinger L, Hutchinson J, et al. A randomized trial of adjuvant chemotherapy in head and neck cancer. J Clin Oncol 3:672–679, 1985.
Rossi A, Molinari R, Boracchi P, Del Vecchio M, Marubini M, Nava M, et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: Results of a 4-year multicenter randomized study. J Clin Oncol 6:1401–1410, 1988.
Rentschler RE, Wilbur DW, Petti GH, Chonkich G, Hilliard D, Camacho E, et al. Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas—a prospective, randomized study. J Clin Oncol 5:278–285, 1987.
Kun LE, Toohill RJ, Holoye PY, Duncavage J, Byhardt R, Ritch P, et al. A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 12:173–178, 1986.
Arcangeli G, Nervi C, Righini R, Creton G, Mirri A, Guerra A. Combined radiation and drugs: The effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer. Radiother Oncol 1:101–107, 1983.
Fazekas JT, Sommer C, Kramer S, Concannon J, Stein J, Griem M, et al. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx, or hypopharynx. Int J Radiat Oncol Biol Phys 6:533–541, 1980.
Schuller DE, Laramore G, Al-Sarraf M, Jacobs J, Pajak TF. Combined therapy for resectable head and neck cancer. A phase III intergroup study. Arch Otoloaryngol Head Neck Surg 115:364–368, 1989.
Ahmad A, Stefani S. Distant metastasis of nasopharyngeal carcinoma: A study of 256 male patients. J Surg Oncol 33:194–197, 1986.
Bedwinek JM, Perez CA, Keys D. Analysis of failures after definitive irradiation for carcinoma of the nasopharynx. Cancer 45:2725–2729, 1980.
Khor TH, Tan EJ, Chia KB. Distant metastases in nasopharyngeal carcinoma. Clin Radiol 29:27–30, 1978.
Vikram B, Mishra UB, Strong EW, Manolatos S. Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys 11:1455–1459, 1985.
Hill BT, Price LA, MacRae KD. The promising role of safe initial non-cisplatin-containing combination chemotherapy in nasopharyngeal tumors. Cancer Invest 5:517–522, 1987.
Dimery IW, Legha SS, Peters LJ, Goepfert H, Oswald MJ. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma. Cancer 60:943–949, 1987.
Cvitkovic E, Bachouchi M, Armand P. Nasopharyngeal carcinoma: Biology, natural history, and therapeutic implications. Hematol Oncol Clin North Am 5:821–838, 1991.
Decker D, Drelichman A, Al-Sarraf M, Crissman J, Reed ML. Chemotherapy for nasopharygeal carcinoma: A 10-year experience. Cancer 58:843–849, 1983.
Al-Sarraf M, Pajak TF, Cooper JS, Mohiuddin M, Herskovik A, Ager PJ. Chemo-radio-therapy in patients with locally advanced nasopharyngeal carcinoma: A Radiation Therapy Oncology Group study. J Clin Oncol 8:1342–1351, 1990.
Richtsmeier WJ, Koch WM, McGuire WP, Poole ME, Chang EH. Phase I-II study of advanced head and neck squamous cell carcinoma patients treated with recombinant human interferon gamma. Arch Otolaryngol Head Neck Surg 116:1271–1277, 1990.
Vlock DR, Johnson J, Meyers E, Day R, Gooding WE, Whiteside T, et al. Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck. Head Neck 13:15–21, 1991.
Cortesina G, De Stefani A, Galeazzi E, Cavallo GP, Jemma C, Giovarelli M, et al. Interleukin-2 injected around tumor draining lymph nodes in head and neck cancer. Head Neck 13:125–131, 1991.
Vlock DR. Immunobiologic aspects of head and neck cancer. Hematol Oncol Clin North Am 5:797–820, 1991.
Valone FH, Gandara DR, Deisseroth AB, Perez EA, Rayner A, Aronson FR, et al. Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/ neck carcinomas. J Immunother 10:207–213, 1991.
Wanebo HJ, Hilal EY, Pinsky CM, Strong EW, Mike V, Hirshaut Y, et al. Randomized trial of levamisole in patients with squamous cancer of the head and neck: A preliminary report. Cancer Treat Rep 62:1663–1669, 1978.
Hong WK, Lippman SM, Itri L, Karp DD, Lee JS, Byers RM, et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 323:795–801, 1990.
La Rocca RV, Stein CA, Meyers CE. Suramin: Prototype of a new generation of antitumor compounds. Cancer Cells 2:106–115, 1990.
Kohn EC, Liotta LA. L651582: A novel antiproliferative and antimetastasis agent. J Natl Cancer Inst 82:54–60, 1990.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pinto, H.A., Jacobs, C. (1995). Distant metastases from head and neck squamous cancer: The role of adjuvant chemotherapy. In: Hong, W.K., Weber, R.S. (eds) Head and Neck Cancer. Cancer Treatment and Research, vol 74. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2023-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2023-8_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5837-4
Online ISBN: 978-1-4615-2023-8
eBook Packages: Springer Book Archive